Zymeworks Inc. Common Stock Cash Flow Quality Index

Latest as of June 2025: 5.21x

Zymeworks Inc. Common Stock cash flow quality index. Zymeworks Inc. Common Stock (ZYME) has a Cash Flow Quality Index of 5.21x as of June 2025. Operating cash flow of $12.07 Million exceeds net income of $2.32 Million, indicating high earnings quality where cash backs reported profits. See financial agility of Zymeworks Inc. Common Stock to measure the company's free cash flow as a share of total liabilities.

Cash Flow Quality Index

5.21x
Operating CF / Net Income

Operating Cash Flow

$12.07 Million
USD

Net Income

$2.32 Million
USD

Data as of

Jun 2025
Most recent filing

Cash Flow Quality Index of Zymeworks Inc. Common Stock (2022–2022)

Cash flow quality index of Zymeworks Inc. Common Stock from 2022 to 2022. Historical Cash Flow Quality Index for Zymeworks Inc. Common Stock across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore Zymeworks Inc. Common Stock (ZYME) cash flow to debt to assess how comfortably operating cash covers total debt obligations.

Zymeworks Inc. Common Stock Cash Flow Quality Index by Year (2022–2022)

Zymeworks Inc. Common Stock cash flow quality index by year from 2022 to 2022. Year-by-year earnings quality comparison for Zymeworks Inc. Common Stock. For the full cash flow conversion analysis, see ZYME cash flow conversion.

Year Quality Index Operating CF (USD) Net Income YoY Change
2022 1.16x $144.11 Million $124.34 Million —
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.